Stem Cell Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Stem Cell stocks.

Stem Cell Stocks Recent News

Date Stock Title
May 15 IPSC Century Therapeutics files to sell 15.87M shares of common stock for holders
May 15 BCLI BrainStorm Cell Therapeutics GAAP EPS of -$0.05 beats by $0.02
May 15 LGVN Longeveron GAAP EPS of -$1.61 beats by $0.39, revenue of $0.55M beats by $0.49M
May 15 LGVN LGVN Making Great Strides
May 14 BCLI BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 14 LGVN Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
May 14 INKT MiNK Therapeutics, Inc. (INKT) Q1 2024 Earnings Call Transcript
May 14 INKT MiNK Therapeutics reports Q1 results
May 14 CELU Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
May 14 INKT MiNK Reports First Quarter 2024 Results
May 13 INKT Why MiNK Therapeutics Stock Is Up 11% Monday
May 13 INKT MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
May 10 LGVN Longeveron announces board transitions
May 10 LGVN Longeveron Announces Board of Directors Planned Transitions
May 10 IPSC Century Therapeutics Inc (IPSC) Q1 2024 Earnings: Aligns with EPS Projections Amid Strategic ...
May 10 LSTA Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
May 10 LSTA Q1 2024 Lisata Therapeutics Inc Earnings Call
May 10 IPSC Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
May 10 LSTA Lisata Therapeutics, Inc. (LSTA) Q1 2024 Earnings Call Transcript
May 9 LSTA Lisata Therapeutics Net Loss Declines From a Year Earlier
Stem Cell

Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells.
In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In a developing embryo, stem cells can differentiate into all the specialized cells—ectoderm, endoderm and mesoderm (see induced pluripotent stem cells)—but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues.
There are three known accessible sources of autologous adult stem cells in humans:
bone marrow, adipose tissue, and blood. Stem cells can also be taken from umbilical cord blood just after birth. Of all stem cell types, autologous harvesting involves the least risk. By definition, autologous cells are obtained from one's own body, just as one may bank his or her own blood for elective surgical procedures.
Adult stem cells are frequently used in various medical therapies (e.g., bone marrow transplantation). Stem cells can now be artificially grown and transformed (differentiated) into specialized cell types with characteristics consistent with cells of various tissues such as muscles or nerves. Embryonic cell lines and autologous embryonic stem cells generated through somatic cell nuclear transfer or dedifferentiation have also been proposed as promising candidates for future therapies. Research into stem cells grew out of findings by Ernest A. McCulloch and James E. Till at the University of Toronto in the 1960s.

Browse All Tags